Tejnaksh Healthcare Limited (BOM:539428)
India · Delayed Price · Currency is INR 18.49
+0.25 (1.37%)
At close: Aug 29, 2025
Tejnaksh Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 124.13 | 128.97 | 121.75 | 117.27 | 126.76 | 119.6 | Upgrade |
Other Revenue | 0 | - | 0.81 | 1.42 | 0.64 | - | Upgrade |
| 124.13 | 128.97 | 122.56 | 118.69 | 127.4 | 119.6 | Upgrade | |
Revenue Growth (YoY) | 1.13% | 5.23% | 3.26% | -6.84% | 6.52% | -31.11% | Upgrade |
Cost of Revenue | 27.15 | 28.13 | 29.46 | 31.25 | 30.4 | 24.4 | Upgrade |
Gross Profit | 96.98 | 100.84 | 93.1 | 87.44 | 97 | 95.2 | Upgrade |
Selling, General & Admin | - | - | 0.58 | 0.34 | 0.21 | 0.12 | Upgrade |
Other Operating Expenses | 60.98 | 60.11 | 55.49 | 48.81 | 48.17 | 57.9 | Upgrade |
Operating Expenses | 71.37 | 69.21 | 65.13 | 57.89 | 55.03 | 64.83 | Upgrade |
Operating Income | 25.62 | 31.63 | 27.97 | 29.55 | 41.97 | 30.37 | Upgrade |
Interest Expense | -3.12 | -3.76 | -6.41 | -6.08 | -4.02 | -4.86 | Upgrade |
Interest & Investment Income | - | - | 2.05 | 1.33 | 0.62 | 0.56 | Upgrade |
Currency Exchange Gain (Loss) | - | - | -0.04 | 0.01 | - | - | Upgrade |
Other Non Operating Income (Expenses) | 4.26 | 4.04 | 0.17 | 0.31 | -0.52 | 0.66 | Upgrade |
EBT Excluding Unusual Items | 26.76 | 31.91 | 23.75 | 25.13 | 38.06 | 26.74 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.45 | -0.06 | Upgrade |
Pretax Income | 26.76 | 31.91 | 23.75 | 25.13 | 37.61 | 26.68 | Upgrade |
Income Tax Expense | 8.32 | 9.61 | 6.11 | 7.21 | 9.5 | 5.99 | Upgrade |
Earnings From Continuing Operations | 18.45 | 22.31 | 17.64 | 17.91 | 28.11 | 20.69 | Upgrade |
Minority Interest in Earnings | 1.38 | 0.97 | 0.12 | -1.09 | -0.88 | -0.16 | Upgrade |
Net Income | 19.83 | 23.28 | 17.76 | 16.83 | 27.24 | 20.53 | Upgrade |
Net Income to Common | 19.83 | 23.28 | 17.76 | 16.83 | 27.24 | 20.53 | Upgrade |
Net Income Growth | -10.37% | 31.06% | 5.55% | -38.22% | 32.67% | -1.78% | Upgrade |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 | Upgrade |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 | Upgrade |
Shares Change (YoY) | -1.19% | -0.36% | - | - | - | 0.00% | Upgrade |
EPS (Basic) | 0.98 | 1.15 | 0.87 | 0.83 | 1.34 | 1.01 | Upgrade |
EPS (Diluted) | 0.98 | 1.15 | 0.87 | 0.83 | 1.34 | 1.01 | Upgrade |
EPS Growth | -9.29% | 31.53% | 5.55% | -38.22% | 32.67% | -1.78% | Upgrade |
Free Cash Flow | - | 1.35 | 35.08 | 12.96 | 1.31 | 7.39 | Upgrade |
Free Cash Flow Per Share | - | 0.07 | 1.73 | 0.64 | 0.06 | 0.36 | Upgrade |
Gross Margin | 78.13% | 78.19% | 75.96% | 73.67% | 76.14% | 79.60% | Upgrade |
Operating Margin | 20.64% | 24.53% | 22.82% | 24.90% | 32.94% | 25.40% | Upgrade |
Profit Margin | 15.97% | 18.05% | 14.49% | 14.18% | 21.38% | 17.16% | Upgrade |
Free Cash Flow Margin | - | 1.05% | 28.63% | 10.92% | 1.03% | 6.18% | Upgrade |
EBITDA | 34.78 | 40.73 | 36.84 | 38.07 | 48.27 | 37.13 | Upgrade |
EBITDA Margin | 28.02% | 31.58% | 30.06% | 32.07% | 37.88% | 31.04% | Upgrade |
D&A For EBITDA | 9.16 | 9.1 | 8.86 | 8.51 | 6.3 | 6.75 | Upgrade |
EBIT | 25.62 | 31.63 | 27.97 | 29.55 | 41.97 | 30.37 | Upgrade |
EBIT Margin | 20.64% | 24.53% | 22.82% | 24.90% | 32.94% | 25.40% | Upgrade |
Effective Tax Rate | 31.08% | 30.11% | 25.73% | 28.70% | 25.25% | 22.44% | Upgrade |
Revenue as Reported | 128.39 | 133.01 | 124.82 | 120.34 | 128.23 | 120.99 | Upgrade |
Advertising Expenses | - | - | 0.57 | 0.26 | 0.12 | 0.12 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.